Bas B. Koolen

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques

Bas B. Koolen, Marie-Jeanne T. F. D. Vrancken Peeters, Tjeerd S. Aukema et al. · Breast Cancer Research and Treatment · 2011 · 146 citations

Positron Emission Tomography, 18F-fdg Pet/ct, Oncologic Imaging +13

Comparing Global Initiative for Asthma (GINA) criteria with the Childhood Asthma Control Test (C-ACT) and Asthma Control Test (ACT)

Bas B. Koolen, Mariëlle W. Pijnenburg, Hein Brackel et al. · European Respiratory Journal · 2011 · 122 citations · Full text

Asthma, Environmental Allergy, Allergy Medicine +20

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

Esther H. Lips, Lennart Mulder, Jorma J. de Ronde et al. · Breast Cancer Research and Treatment · 2013 · 114 citations · Full text

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

Bas B. Koolen, Marcus Peeters, Jelle Wesseling et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 102 citations

Breast Oncology, Neoadjuvant Chemotherapy, Breast Cancer Patients +7

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

Bas B. Koolen, Kenneth E. Pengel, Jelle Wesseling et al. · The Breast · 2013 · 90 citations · Full text